Early effects of low versus high dose atorvastatin treatment on coagulation and inflammation parameters in patients with acute coronary syndromes

International Journal of Cardiology

Volumn 128, Issue 2, 2008, Pages 282-284

  Ordulu, Emine ^a   Erdogan, Okan ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

Acute coronary syndrome; Coagulation; CRP; Inflammation; Statin; vWF

Indexed keywords

ATORVASTATIN; BLOOD CLOTTING FACTOR 7; C REACTIVE PROTEIN; PLACEBO; VON WILLEBRAND FACTOR;

ACUTE CORONARY SYNDROME; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HUMAN; INFLAMMATION; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; BLOOD COAGULATION; C-REACTIVE PROTEIN; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATION; PYRROLES;

EID: 47749119560     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.06.030     Document Type: Article

References (13)

1. Kinlay S., Schwartz G.G., Olsson A.G., et al. Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering Study Investigators. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study. Circulation 108 13 (2003) 1560-1566
2. Correia L.C., Sposito A.C., Lima J.C., et al. Anti-inflammatory effect of atorvastatin (80 mg) in unstable angina pectoris and non-Q-wave acute myocardial infarction. Am J Cardiol 92 3 (2003) 298-301
3. Libby P. Current concepts of pathogenesis of acute soronary syndromes. Circulation 104 (2001) 365-372
4. Davies M.J. Stability and instability; two faces of coronary atherosclerosis. Circulation 94 (1996) 2013-2020
5. Bruni F., Pasqui A.L., Pastorelli M., et al. Effect of atorvastatin on different fibrinolysis mechanisms in hypercholesterolemic subjects. Int J Cardiol 95 2-3 (2004) 269-274
6. Ercan E., Tengiz İ., Altuglu İ., et al. Atorvastatin treatment decreases inflammatory and proteolytic activity in patients with hypercholesterolemia. Kardiol Pol 60 5 (2004) 454-458
7. Toss H., Lindahl B., Siegbahn A., and Wallentin L. Prognostic influence of increased fibrinogen and CRP levels in unstable coronary artery disease. FRISC Study Group. Circulation 96 (1997) 4204-4210
8. Liuzzo G., Biasucci L.M., Gallimore J.R., et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 331 7 (1994) 417-424
9. Haverkate F., Thompson S.G., Pyke S.D., Gallimore J.R., and Pepys M.B. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 349 (1997) 462-466
10. Biasucci L.M., Liuzzo G., Grillo R.L., et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 99 7 (1999) 855-860
11. Morrow D.A., Rifai N., Antman E.M., et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: TIMI-IIA substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 31 7 (1998) 1460-1465
12. Schwartz G.G., Olsson A.G., Ezekowitz M.D., et al. Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study. JAMA 285 13 (2001) 1711-1718
13. Tousoulis D., Bosinakou E., Kotsopoulou M., Antoniades C., Katsi V., and Stefanadis C. Effects of early administration of atorvastatin treatment on thrombotic process in normocholesterolemic patients with unstable angina. Int J Cardiol 106 3 (2006) 333-337